iHuman Inc. Files March 2025 6-K Report
Ticker: IH · Form: 6-K · Filed: Mar 25, 2025 · CIK: 1814423
Sentiment: neutral
Topics: 6-K, disclosure, foreign-private-issuer
TL;DR
iHuman Inc. filed its March 6-K, nothing major but good to keep an eye on.
AI Summary
iHuman Inc. filed a Form 6-K on March 25, 2025, reporting for the month of March 2025. The filing includes a press release as Exhibit 99.1. Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of the company.
Why It Matters
This filing provides routine updates and disclosures for iHuman Inc., a foreign private issuer, which is important for investors tracking the company's ongoing compliance and reporting.
Risk Assessment
Risk Level: low — This is a routine filing (6-K) that typically contains press releases or other periodic disclosures, not significant financial events.
Key Players & Entities
- iHuman Inc. (company) — Registrant
- Vivien Weiwei Wang (person) — Director and Chief Financial Officer
- March 25, 2025 (date) — Filing Date
- 001-39591 (company) — SEC File Number
FAQ
What type of report is this filing?
This filing is a Form 6-K, a Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16 Under the Securities Exchange Act of 1934.
Who signed this report on behalf of iHuman Inc.?
Vivien Weiwei Wang, Director and Chief Financial Officer, signed the report on behalf of iHuman Inc.
What is the principal executive office address of iHuman Inc.?
The principal executive offices are located at Building A, No. 1 Wangjing East Road, Chaoyang District, Beijing 100102, People's Republic of China.
What is the filing date of this Form 6-K?
The filing date is March 25, 2025.
What exhibit is included with this Form 6-K?
Exhibit 99.1, a Press Release, is included with this Form 6-K.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 25, 2025 by Vivien Weiwei Wang regarding iHuman Inc. (IH).